Citi Upgrades Biogen (BIIB) to Buy
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $232.62 -0.19%
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade BIIB Now!
Citi upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $187.00 (from $160.00).
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $160.30 yesterday, with a 52 week range of $114.53-$167.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $160.30 yesterday, with a 52 week range of $114.53-$167.35.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
- Wedbush Upgrades Pacific Sunwear of California (PSUN) to Neutral
- Toll Bros. (TOL) Q2 Solid but Not Much Better Than Peers
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Citi
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
